DEA Archived Press Releases

Press Releases before January 20, 2025
35 Results - Showing 31 to 35
PRESS RELEASE

DEA Washington Division Issues Warning: “One Pill Can Kill”

Washington, D.C. – Jarod Forget, Special Agent in Charge (SAC) of the DEA Washington Division, is alerting all area residents to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid, fentanyl. Manufactured by Mexican drug trafficking organizations, and marketed as a medication such as...
PRESS RELEASE

U.S. Navy Petty Officer Pleads Guilty to Role in Multi-State Anabolic Steroid Trafficking Network

NORFOLK, Va. – Today, a Jacksonville, Florida man was the sixth and final defendant to enter a guilty plea for his role in a multi-state anabolic steroid conspiracy that operated in multiple states across the country. According to court documents, law enforcement received information in February 2020 that Erik Eckert...
PRESS RELEASE

Dark Web Vendor of Opioids and Counterfeit U.S. Currency Pleads Guilty

ALEXANDRIA, Va. – A Utica, New York man pleaded guilty yesterday to charges relating to his sale of over $1.2 million in opioid pills and counterfeit U.S. currency on multiple dark web criminal marketplaces. According to court documents, from around October 2016 through February 2021, Albie Pagan, 65, operated under...
PRESS RELEASE

Bakersfield man sentenced for structuring synthetic drug proceeds

FRESNO, Calif. — Majed Bashir Akroush, aka Magic Mike, 52, of Bakersfield, was sentenced today to two years and nine months in prison for conspiring to structure over $700,000 in cash withdrawals from four different bank accounts associated with his internet businesses that sold synthetic marijuana, U.S. Attorney McGregor W...
PRESS RELEASE

Search of Concord warehouse leads to re-arrest of dark web vendor

OAKLAND, Calif. – Jeremy Donagal was charged in a criminal complaint filed this morning with possession of equipment for producing counterfeit drugs as well as the manufacture and sale of counterfeit drugs in a scheme to distribute counterfeit generic alprazolam (the active ingredient in the brand-name anti-anxiety medication Xanax), announced...